Reach Us +44-2036084181
Preeclampsia And Its Associated Serum Markers | 50272
ISSN: 2155-9880

Journal of Clinical & Experimental Cardiology
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Preeclampsia and its associated serum markers

International Conference on Hypertension & Healthcare

Fizza Hassan, Sheikh Mohammad Anwer Ali, Tooba Sajid, Uroosa Asif, Mahek Samnani, Narmeen Shahid, Kaniz Hira Bibi, Afia Azam and Musleh Uddin Kalar

Abbasi Shaheed Hospital, Pakistan Karachi Medical and Dental College, Pakistan Sind Medical College, Pakistan Qureshi Clinic of Family Medicine, Pakistan

Posters & Accepted Abstracts: J Clin Exp Cardiolog

DOI: 10.4172/2155-9880.C1.042

Objective: To determine the positive role of maternal hematological serum markers in gestation for preeclampsia. Introduction: Preeclampsia affects 5% of all pregnancies and is a significant cause of maternal and neonatal morbidity and mortality. Early risk stratification may improve the identification of women at highest risk for preeclampsia and provide an opportunity for intervention. Studies have evaluated serum angiogenic markers in gestation for the commencement of preeclampsia. Methods: Sample size was estimated by using the World Health Organization (W.H.O) software. Main clinical variables were pregnancy associated plasma protein-A (PAPP-A) for aneuploidy screening, placental protein-13 (PP-13) for immune functions, soluble fms-like tyrosine kinase-1 (sFlt-1) for placental ischemia, inhibin-A for down's syndrome and endoglin for vascular permeability and hypertension were defined in reduced and full models of ANOVA. (Reduced model Y= β0 + β1X1 + ε and the full model Y= β0+β1X1+ β2X2 + β3X3 + β4X4 + β5X5 + ε). Results: Serum markers PAPP-A (OR 1.97; 95% (CI): 1.07-2.59), PP-13 (OR 2.76; 95% (CI): 2.07-3.59), sFlt-1 (OR 1.79; 95% (CI): 1.58-3.45), inhibin-A (OR 2.37; 95% (CI): 1.53-4.67) were statistically significant (p<0.001) and endoglin (OR 1.34; 95% (CI): 0.15- 2.59) was not significant( p>0.05). (Reduced model Y= β0 + β1PAPP-A + ε and the full model Y= β0 + β1PAPP-A + β2PP-13 + β3 sFlt-1 + β4 inhibin-A + β5 endoglin + ε). Serum PAPP-A and serum sFlt-1 showed a highly significant positive correlation (r=0.81; p<0.001). Serum PAPP-A also showed a moderate correlation with PP-13 (r=0.62; p<0.01), inhibin-A (r=0.58; p<0.01). Conclusion: Both, 1st trimester PAPP-A levels and sFlt-1 levels were notably lower in women who afterward developed preeclampsia.

Fizza Hassan is a student of Karachi Medical and Dental College. She is a medical student researcher and has contributed in a couple of papers in international medical journals. Her medical rotations include, Department of Medicine, Gynecology and Obstetrics, and Dermatology at Karachi Medical and Dental College, Abbasi Shaheed Hospital. During her electives she worked in outdoor patient department, wards, clinics and operation room. In the patient setting, she has worked with the medical team in caring for the needs of pregnant women and continued to care for them on the postpartum floor and also at the department of Medicine.

Email: [email protected]